Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Pennywort leaf (Centella asiatica) contains triterpene glycosides including asiaticoside and madecassoside that inhibit pro-inflammatory cytokines TNF-α, IL-6, and IL-1β while modulating NF-κB and MAPK pathways. These compounds enhance nerve growth factor production and strengthen blood vessel integrity through collagen synthesis stimulation.
Reported Benefits (Provisional)
Origin & History
Pennywort leaf (Centella asiatica), also known as Gotu Kola, is a perennial herb native to wetlands in Asia, Africa, and the Pacific Islands. It thrives in tropical and subtropical regions. This botanical is highly valued in functional nutrition for its neuroprotective, skin-regenerative, and adaptogenic properties.
Research Narrative (Provisional)
Extensive research, including in vitro, animal, and some human clinical studies, validates Pennywort leaf's neuroprotective, anti-inflammatory, and immune-supportive properties. Evidence also supports its role in skin regeneration and cognitive enhancement, aligning with its traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Triterpenoids (asiaticoside, madecassoside, asiatic acid), Flavonoids, Polyphenols, Saponins - Vitamins A, C, B-complex - Calcium, Magnesium, Potassium
Reported Mechanism (Provisional)
Asiaticoside, madecassoside, asiatic acid, and madecassic acid inhibit pro-inflammatory pathways including NF-κB, MAPKs, and PI3K/AKT while modulating M1/M2 macrophage balance. These triterpenes activate antioxidant enzymes CAT and SOD, reduce oxidative stress markers, and stimulate collagen synthesis for tissue repair. Flavonoids and tannins contribute additional antimicrobial effects by inhibiting microbial enzymes and scavenging DPPH radicals.
Clinical Narrative (Provisional)
Current evidence consists primarily of preclinical studies with limited human clinical trials providing specific quantitative outcomes. In vitro studies show 21.17% DPPH radical scavenging activity and 30-40% COX-2 expression inhibition in murine models. Transgenic Drosophila Parkinson's models demonstrated delayed climbing ability loss and reduced brain oxidative stress with C. asiatica leaf extracts. While extensive animal and cell culture research supports neuroprotective and anti-inflammatory properties, robust human clinical trials with specific sample sizes and statistical outcomes are needed for clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.